Mo1906 – Combination Therapy of Vedolizumab and Tofacitinib in IBD Patients with Chronic Active Refractory Disease Course and Spondylarthritis

Title
Mo1906 – Combination Therapy of Vedolizumab and Tofacitinib in IBD Patients with Chronic Active Refractory Disease Course and Spondylarthritis
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume 156, Issue 6, Pages S-881
Publisher
Elsevier BV
Online
2019-05-07
DOI
10.1016/s0016-5085(19)39173-5

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started